Comparative incidence of pregnancy outcomes in thrombophilia-positive women from the NOH-APS observational study

Blood

Volumn 123, Issue 3, 2014, Pages 414-421

  Bouvier, Sylvie ^a,b   Cochery Nouvellon, Éva ^a,b   Lavigne Lissalde, Géraldine ^a,b   Mercier, Érick ^a,b   Fabbro Peray, Pascale ^a   Balducchi, Jean Pierre ^a   Marès, Pierre ^a   Gris, Jean Christophe ^a,b  

^a NÎMES UNIVERSITY HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; ENOXAPARIN; JANUS KINASE 2; PROTHROMBIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS DEATH; FETUS WASTAGE; GENETIC POLYMORPHISM; GESTATIONAL AGE; HETEROZYGOTE; HIGH RISK PREGNANCY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; RECURRENT ABORTION; SPONTANEOUS ABORTION; THROMBOPHILIA; YOUNG ADULT;

ABORTION, HABITUAL; ADOLESCENT; ADULT; FACTOR V; FEMALE; FETAL DEATH; FIBRINOLYTIC AGENTS; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INCIDENCE; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROTHROMBIN; THROMBOPHILIA; YOUNG ADULT;

EID: 84893129642     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-09-525014     Document Type: Article

References (26)

1. Robertson L, Wu O, Langhorne P., et al.; Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Thrombophilia in (Pubitemid 43381552)
2. Rodger MA, Betancourt MT, Clark P, et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: A systematic review and meta-analysis of prospective cohort studies. PLoS Med. 2010; 7(6): e1000292.
3. Gris JC, Bouvier S, Molinari N., et al. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood. 2012; 119(11): 2624-2632.
4. Gris JC, Mercier E, Quéré I, et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood. 2004; 103(10): 3695-3699. (Pubitemid 38596284)
5. Giannakopoulos B, Krilis SA. How I treat the antiphospholipid syndrome. Blood. 2009; 114(10): 2020-2030.
6. Wisser J, Dirschedl P, Krone S. Estimation of gestational age by transvaginal sonographic measurement of greatest embryonic length in dated human embryos. Ultrasound Obstet Gynecol. 1994; 4(6): 457-462.
7. Salomon LJ, Duyme M, Crequat J., et al. French fetal biometry: reference equations and comparison with other charts. Ultrasound Obstet Gynecol. 2006; 28(2): 193-198. (Pubitemid 44265176)
8. Schulman S, Kearon C; Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005; 3(4): 692-694. (Pubitemid 41647882)
9. D'Ippolito S., Di Nicuolo F, Marana R, et al. Emerging nonanticoagulant role of low molecular weight heparins on extravillous trophoblast functions and on heparin binding-epidermal growth factor and cystein-rich angiogenic inducer 61 expression. Fertil Steril. 2012; 98(4): 1028-1036, e1-e2.
10. Suga N, Sugimura M, Koshiishi T., Yorifuji T, Makino S, Takeda S. Heparin/heparan sulfate/CD44-v3 enhances cell migration in term placenta-derived immortalized human trophoblast cells. Biol Reprod. 2012; 86(5): 134, 1-8.
11. Ball E, Bulmer JN, Ayis S, Lyall F., Robson SC. Late sporadic miscarriage is associated with abnormalities in spiral artery transformation and trophoblast invasion. J Pathol. 2006; 208(4): 535-542. (Pubitemid 43329340)
12. Ball E, Robson SC, Ayis S, Lyall F., Bulmer JN. Early embryonic demise: no evidence of abnormal spiral artery transformation or trophoblast invasion. J Pathol. 2006; 208(4): 528-534. (Pubitemid 43329339)
13. Schwenke M, Knöfler M, Velicky P., et al. Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors. PLoS ONE. 2013; 8(1): e54336.
14. Oberkersch R, Attorresi AI, Calabrese GC. Low-molecular-weight heparin inhibition in classical complement activation pathway during pregnancy. Thromb Res. 2010; 125(5): e240-e245.
15. Buurma A, Cohen D, Veraar K., et al. Preeclampsia is characterized by placental complement dysregulation. Hypertension. 2012; 60(5): 1332-1337.
16. Lockwood CJ, Huang SJ, Krikun G, et al. Decidual hemostasis, inflammation, and angiogenesis in pre-eclampsia. Semin Thromb Hemost. 2011; 37(2): 158-164.
17. Goldenberg RL, Mayberry SK, Copper R.L., Dubard MB, Hauth JC. Pregnancy outcome following a second-trimester loss. Obstet Gynecol. 1993; 81(3): 444-446. (Pubitemid 23085308)
18. Frias AE J.r., Luikenaar RA, Sullivan A.E., et al. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol. 2004; 104(3): 521-526. (Pubitemid 40458838)
19. Edlow AG, Srinivas SK, Elovitz MA. Second-trimester loss and subsequent pregnancy outcomes: What is the real risk? Am J Obstet Gynecol. 2007; 197(6): 581. e1-6.
20. Coppens M, Folkeringa N, Teune M.J., et al. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost. 2007; 5(7): 1444-1448. (Pubitemid 46965373)
21. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2): 295-306.
22. Tormene D, Grandone E, De Stefano V, et al. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation. Thromb Haemost. 2012; 107(3): 477-484.
23. de Vries J.I., van Pampus MG, Hague WM, Bezemer PD, Joosten JH; FRUIT Investigators. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT. J Thromb Haemost. 2012; 10(1): 64-72.
24. Kolte AM, Nielsen HS, Moltke I, et al. A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggests genetic linkage. Mol Hum Reprod. 2011; 17(6): 379-385.
25. Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141 (2 Suppl): e691S-e736S.
26. Bhattacharya S, Townend J, Shetty A., Campbell D, Bhattacharya S. Does miscarriage in an initial pregnancy lead to adverse obstetric and perinatal outcomes in the next continuing pregnancy? BJOG. 2008; 115(13): 1623-1629.